One Canadian said it felt like a painful poke to his brain. An American heard crunching sounds in her head. A Frenchwoman suffered a severe nosebleed. Others got headaches, cried or were left in shock.

They were all tested for COVID-19 with deep nasal swabs. While many people have no complaints about their experience, for some, the swab test — a vital tool in the global battle against the coronavirus — engenders visceral dislike, severe squirming or buckled knees.

“It felt like someone was going right into the reset button of my brain to switch something over,” Paul Chin, a music producer and DJ in Toronto, said of his nasal swab test. “There’s truly nothing like it.”

“Oh, my goodness," he added, "the swab just going farther back into my nose than I’d ever imagined or would have guessed. It’s such a long and sharp and pointy kind of thing.”

Since the coronavirus emerged, millions of swabs have been stuck into millions of noses to test for a pernicious virus that has killed millions across the planet. One of the ways to fight the virus, officials say, is to test widely and to test often. The imperative has been to use a test that people are willing to take repeatedly.

The swab generally fits the bill.

In some parts of the United States, health workers hand people the swab to test themselves, assuring a level of personal comfort. To many South Africans, the only COVID-19 test is a painful one — you see stars or gag because a swab goes down your throat.

The range of swabbing raises questions: Who is doing it right? How deeply should the swab slide into your nostril? How long should it spend up there? Does an accurate test have to be uncomfortable? Unfairly or not, some countries have reputations for brutal tests.

First, a brief anatomy lesson: No, the swab is not actually stabbing your brain.

The swab traverses a dark passage that leads to the nasal cavity. That is enclosed by bone covered in soft, sensitive tissue. At the back of this cavity — more or less in line with your earlobe — is your nasopharynx, where the back of your nose meets the top of your throat. It is one of the places where the coronavirus actively replicates, and it is where you are likely to get a good sample of the virus.

Wariness about the test may arise from a simple fact: Most people cannot stand having something shoved so far up their nose. Furthermore, the tests conjure some of our darkest fears: of things that can crawl into our orifices and burrow into our brain.

“People aren’t used to feeling that part of their body,” Dr. Noah Kojima, a resident physician at the University of California, Los Angeles and an expert in infectious diseases, said about swabs touching the nasopharynx.

Pain enters the picture when the swab — a tuft of nylon attached to a lollipop-like stick — is administered at the wrong angle, said Dr. Yuka Manabe, a professor of medicine specializing in infectious diseases at Johns Hopkins University School of Medicine.

“If you don’t tip your head back, you don’t get to the throat,” she said. “You’re smashing into someone’s bone.”

Chin described his test as a “brain poke” and compared the burning sensation to the effects of breathing in spice.

“Your whole face is kind of ready to leak,” he said, adding, “I don’t really know that there’s any way to be prepared for it.”

There are three main kinds of COVID nasal swab tests: nasopharyngeal (the deepest), mid-turbinate (the middle) and anterior nares (the shallow part of your nose). Early in the pandemic, the deep nose swab was administered widely and aggressively to adults because the method worked when testing for influenza and SARS. Although the science is evolving, experts tend to agree that the deepest swab is the most accurate.

According to a review of studies published in July in PLOS One, a science journal, nasopharyngeal swabs are 98% accurate; shallow swabs are 82% to 88% effective; mid-turbinate swabs perform similarly.

In South Korea, nasopharyngeal swabs remain the gold standard for COVID testing, said Seung-ho Choi, a deputy director of risk communication at the Korea Disease Control and Prevention Agency.

“Depending on the skill of the medical staff, it may or may not hurt,” he said. But he said: “The nasopharyngeal test is the most accurate. That’s why we keep doing them.”

The WHO has guidelines about how best to test; complications have been rare. Australian guidelines say swabs should go a few centimeters up adult nostrils. The U.S. Centers for Disease Control and Prevention says the mid-turbinate swab should usually be inserted less than an inch, or until it meets resistance. Some testers swab both nostrils.

The KDCA’s guidelines allow testers some leeway on how to scrape the nasopharynx (wiggling or spinning the swab, or both). Choi said the experience depends on the brand of swab, the patient’s pain tolerance, the anatomical structure of the nasal cavity and the tester’s proficiency.

Dr. Lee Jaehyeon, a professor of laboratory medicine at Jeonbuk National University who helped develop the Korean government’s COVID-testing guidelines, said the test posed as little risk as drawing blood.

But walking out of a clinic in Seoul this month, some people were sneezing, rubbing their eyes or blowing their noses. One or two were crying.

“It felt like the swab was scraping my brain,” said Chu Yumi, 19.

Kim Kai, 28, who had bloodshot eyes, said, “I think my nose is about to bleed.”

Lee Eunju and Lee Jumi, both 16, said they never wanted to get nasal swabs again. Eunju said it felt as if chili powder had been dumped down her nostrils. Jumi said, “It hurt so much.”

Lee Jaehyeon said the discomfort is a trade-off for accuracy.

“This does not mean we can ignore the pain that each patient feels,” he said.

Many people tolerate the test just fine. Dr. Paul Das, a family physician at St. Michael’s Hospital in the Unity Health Toronto network, said children tended to have a tougher time.

Some people chalk up their experiences to testers’ technique or their personalities.

“It stings, it’s a little uncomfortable, but I think the person was very gentle,” said Kim Soon Ok, 65, outside a clinic in Seoul.

Issa Ba, a 31-year-old soccer player, recalled: “I had my COVID-19 test in Conakry, Guinea, in August before I came to Senegal. I felt a little pain when they put the stick in my nose, but it was not that bad. And I have endured much more intense pain. I am a man.”

Some countries aim to standardize the tests and remove human error. Developers in Denmark, Japan, Singapore and Taiwan have invented robots to do the job.

Manabe, of Johns Hopkins, insists the swabbing should not hurt.

Still, painful tales abound.

Women often report worse pain than men, studies show, but this could be because of a design bias: Some swabs may be too large for a woman’s facial anatomy.

Briana Mohler, 28, suffered a nose swabbing in Minnesota in 2020 so excruciating that she could “hear crunching.”

Audrey Benattar, who recently moved back to Marseille, France, recalled her trip to a Montreal hospital in May to give birth. There, a nasal COVID swab left her with burst blood vessels and balloon catheters in both nostrils to stem the bleeding.

“I’ve never seen so much blood in my life,” Benattar, 34, said.

Some argue that nose swabs rank relatively low on the scale of squeamish coronavirus tests.

This year, China required some travelers from overseas, including diplomats, to submit to anal COVID swab tests, infuriating foreign governments.

One Canadian said it felt like a painful poke to his brain. An American heard crunching sounds in her head. A Frenchwoman suffered a severe nosebleed. Others got headaches, cried or were left in shock.

One Canadian said it felt like a painful poke to his brain. An American heard crunching sounds in her head. A Frenchwoman suffered a severe nosebleed. Others got headaches, cried or were left in shock. They were all tested for COVID-19 with deep nasal swabs. While many people have no complaints about their experience, for some, the swab test — a vital tool in the global battle against the coronavirus — engenders visceral dislike, severe squirming or buckled knees. “It felt like someone was going right into the reset button of my brain to switch something over,” Paul Chin, a music producer and DJ in Toronto, said of his nasal swab test. “There’s truly nothing like it.” “Oh, my goodness," he added, "the swab just going farther back into my nose than I’d ever imagined or would have guessed. It’s such a long and sharp and pointy kind of thing.” Since the coronavirus emerged, millions of swabs have been stuck into millions of noses to test for a pernicious virus that has killed millions across the planet. One of the ways to fight the virus, officials say, is to test widely and to test often. The imperative has been to use a test that people are willing to take repeatedly. The swab generally fits the bill. In some parts of the United States, health workers hand people the swab to test themselves, assuring a level of personal comfort. To many South Africans, the only COVID-19 test is a painful one — you see stars or gag because a swab goes down your throat. The range of swabbing raises questions: Who is doing it right? How deeply should the swab slide into your nostril? How long should it spend up there? Does an accurate test have to be uncomfortable? Unfairly or not, some countries have reputations for brutal tests. First, a brief anatomy lesson: No, the swab is not actually stabbing your brain. The swab traverses a dark passage that leads to the nasal cavity. That is enclosed by bone covered in soft, sensitive tissue. At the back of this cavity — more or less in line with your earlobe — is your nasopharynx, where the back of your nose meets the top of your throat. It is one of the places where the coronavirus actively replicates, and it is where you are likely to get a good sample of the virus. Wariness about the test may arise from a simple fact: Most people cannot stand having something shoved so far up their nose. Furthermore, the tests conjure some of our darkest fears: of things that can crawl into our orifices and burrow into our brain. “People aren’t used to feeling that part of their body,” Dr. Noah Kojima, a resident physician at the University of California, Los Angeles and an expert in infectious diseases, said about swabs touching the nasopharynx. Pain enters the picture when the swab — a tuft of nylon attached to a lollipop-like stick — is administered at the wrong angle, said Dr. Yuka Manabe, a professor of medicine specializing in infectious diseases at Johns Hopkins University School of Medicine. “If you don’t tip your head back, you don’t get to the throat,” she said. “You’re smashing into someone’s bone.” Chin described his test as a “brain poke” and compared the burning sensation to the effects of breathing in spice. “Your whole face is kind of ready to leak,” he said, adding, “I don’t really know that there’s any way to be prepared for it.” There are three main kinds of COVID nasal swab tests: nasopharyngeal (the deepest), mid-turbinate (the middle) and anterior nares (the shallow part of your nose). Early in the pandemic, the deep nose swab was administered widely and aggressively to adults because the method worked when testing for influenza and SARS. Although the science is evolving, experts tend to agree that the deepest swab is the most accurate. According to a review of studies published in July in PLOS One, a science journal, nasopharyngeal swabs are 98% accurate; shallow swabs are 82% to 88% effective; mid-turbinate swabs perform similarly. In South Korea, nasopharyngeal swabs remain the gold standard for COVID testing, said Seung-ho Choi, a deputy director of risk communication at the Korea Disease Control and Prevention Agency. “Depending on the skill of the medical staff, it may or may not hurt,” he said. But he said: “The nasopharyngeal test is the most accurate. That’s why we keep doing them.” The WHO has guidelines about how best to test; complications have been rare. Australian guidelines say swabs should go a few centimeters up adult nostrils. The U.S. Centers for Disease Control and Prevention says the mid-turbinate swab should usually be inserted less than an inch, or until it meets resistance. Some testers swab both nostrils. The KDCA’s guidelines allow testers some leeway on how to scrape the nasopharynx (wiggling or spinning the swab, or both). Choi said the experience depends on the brand of swab, the patient’s pain tolerance, the anatomical structure of the nasal cavity and the tester’s proficiency. Dr. Lee Jaehyeon, a professor of laboratory medicine at Jeonbuk National University who helped develop the Korean government’s COVID-testing guidelines, said the test posed as little risk as drawing blood. But walking out of a clinic in Seoul this month, some people were sneezing, rubbing their eyes or blowing their noses. One or two were crying. “It felt like the swab was scraping my brain,” said Chu Yumi, 19. Kim Kai, 28, who had bloodshot eyes, said, “I think my nose is about to bleed.” Lee Eunju and Lee Jumi, both 16, said they never wanted to get nasal swabs again. Eunju said it felt as if chili powder had been dumped down her nostrils. Jumi said, “It hurt so much.” Lee Jaehyeon said the discomfort is a trade-off for accuracy. “This does not mean we can ignore the pain that each patient feels,” he said. Many people tolerate the test just fine. Dr. Paul Das, a family physician at St. Michael’s Hospital in the Unity Health Toronto network, said children tended to have a tougher time. Some people chalk up their experiences to testers’ technique or their personalities. “It stings, it’s a little uncomfortable, but I think the person was very gentle,” said Kim Soon Ok, 65, outside a clinic in Seoul. Issa Ba, a 31-year-old soccer player, recalled: “I had my COVID-19 test in Conakry, Guinea, in August before I came to Senegal. I felt a little pain when they put the stick in my nose, but it was not that bad. And I have endured much more intense pain. I am a man.” Some countries aim to standardize the tests and remove human error. Developers in Denmark, Japan, Singapore and Taiwan have invented robots to do the job. Manabe, of Johns Hopkins, insists the swabbing should not hurt. Still, painful tales abound. Women often report worse pain than men, studies show, but this could be because of a design bias: Some swabs may be too large for a woman’s facial anatomy. Briana Mohler, 28, suffered a nose swabbing in Minnesota in 2020 so excruciating that she could “hear crunching.” Audrey Benattar, who recently moved back to Marseille, France, recalled her trip to a Montreal hospital in May to give birth. There, a nasal COVID swab left her with burst blood vessels and balloon catheters in both nostrils to stem the bleeding. “I’ve never seen so much blood in my life,” Benattar, 34, said. Some argue that nose swabs rank relatively low on the scale of squeamish coronavirus tests. This year, China required some travelers from overseas, including diplomats, to submit to anal COVID swab tests, infuriating foreign governments.

Must the swab go that far up your nose to test for Covid?

Nearly 11 per cent of those in the national capital who tested negative for COVID-19 in rapid antigen tests (RAT) but had symptoms for the disease were found to have been afflicted by the viral infection in RT-PCR test between September 1 and November 7, according to official data.

Out of the 56,862 symptomatic patients who tested negative in rapid antigen tests, 32,903 were retested through RT-PCR and of them 3,524 were found COVID-19 positive, according to the data shared by health authorities in response to an RTI query filed by a PTI reporter.

Also read|&nbsp;<a href="https://www.wionews.com/india-news/india-is-speeding-up-review-of-pfizer-astrazeneca-covid-19-vaccines-report-348139" hreflang="en">India is speeding up review of Pfizer, AstraZeneca COVID-19 vaccines: Report</a>

In order to effectively curb the spread of coronavirus infection, the Union Health Ministry had in September asked all states and Union Territories to mandatorily retest all symptomatic cases found COVID-19 negative in rapid antigen tests through RT-PCR so that no positive case is missed.

For Delhi, the case positivity rate in RT-PCR, which is considered the gold standard for COVID-19 screening, was 20.97 per cent in September, while it was only 4.77 per cent when it comes to rapid antigen test, the RTI reply stated.

Also read|&nbsp;<a href="https://www.wionews.com/india-news/new-smartphone-based-covid-19-test-gives-results-in-less-than-30-minutes-348091" hreflang="en">New smartphone-based COVID-19 test gives results in less than 30 minutes</a>

In October, positivity rates of Reverse Transcription Polymerase Chain Reaction (RT-PCR) and rapid antigen test were 16.76 per cent and 4.58 per cent respectively. Between November 1 and 7 the rapid antigen positivity rate was 8.16 per cent while for RT-PCR it was 27.2 per cent.

According to the RTI reply, out of 27,533 symptomatic negative cases in rapid antigen test in September, only 4,597 were retested through RT-PCR and 623 found COVID-19 positive. The next month, 24,737 out of 26,316 symptomatic negative cases were retested through RT-PCR and 2,300 were found to have contracted the virus.

Also read|&nbsp;<a href="https://www.wionews.com/india-news/india-records-32981-new-covid-19-cases-391-deaths-in-the-last-24-hours-348038" hreflang="en">India records 32,981 new COVID-19 cases, 391 deaths in the last 24 hours</a>

Between November 1 and 7, health authorities retested 3,569 of 4,013 symptomatic rapid antigen test negative cases and 601 were found infected with COVID-19, the RTI reply revealed.

Union Home Minister Amit Shah had chaired high-level meeting on November 15 and gave 12 instructions, following a fresh spike in the number of COVID-19 cases in the national capital.

However, there has been decrease in the number of coronavirus cases in the last few days in Delhi and the city's capacity of conducting RT-PCR tests has significantly has increased.

On Saturday, the national capital registered 3,419 new coronavirus cases, taking the infection tally to over 5.8 lakh, while the death toll rose to 9,574 with 77 more fatalities. The new cases came out of a record 81,473 tests, including 35,352 RT-PCR tests and the positivity rate slipped to 4.2 per cent from 4.78 per cent the previous day.

Nearly 11 per cent of those in the national capital who tested negative for COVID-19 in rapid antigen tests (RAT) but had symptoms for the disease were found to have been afflicted by the viral infection in RT-PCR test between September 1 and November 7, according to official data.

Nearly 11 per cent of those in the national capital who tested negative for COVID-19 in rapid antigen tests (RAT) but had symptoms for the disease were found to have been afflicted by the viral infection in RT-PCR test between September 1 and November 7, according to official data. Out of the 56,862 symptomatic patients who tested negative in rapid antigen tests, 32,903 were retested through RT-PCR and of them 3,524 were found COVID-19 positive, according to the data shared by health authorities in response to an RTI query filed by a PTI reporter. Also read| India is speeding up review of Pfizer, AstraZeneca COVID-19 vaccines: Report In order to effectively curb the spread of coronavirus infection, the Union Health Ministry had in September asked all states and Union Territories to mandatorily retest all symptomatic cases found COVID-19 negative in rapid antigen tests through RT-PCR so that no positive case is missed. For Delhi, the case positivity rate in RT-PCR, which is considered the gold standard for COVID-19 screening, was 20.97 per cent in September, while it was only 4.77 per cent when it comes to rapid antigen test, the RTI reply stated. Also read| New smartphone-based COVID-19 test gives results in less than 30 minutes In October, positivity rates of Reverse Transcription Polymerase Chain Reaction (RT-PCR) and rapid antigen test were 16.76 per cent and 4.58 per cent respectively. Between November 1 and 7 the rapid antigen positivity rate was 8.16 per cent while for RT-PCR it was 27.2 per cent. According to the RTI reply, out of 27,533 symptomatic negative cases in rapid antigen test in September, only 4,597 were retested through RT-PCR and 623 found COVID-19 positive. The next month, 24,737 out of 26,316 symptomatic negative cases were retested through RT-PCR and 2,300 were found to have contracted the virus. Also read| India records 32,981 new COVID-19 cases, 391 deaths in the last 24 hours Between November 1 and 7, health authorities retested 3,569 of 4,013 symptomatic rapid antigen test negative cases and 601 were found infected with COVID-19, the RTI reply revealed. Union Home Minister Amit Shah had chaired high-level meeting on November 15 and gave 12 instructions, following a fresh spike in the number of COVID-19 cases in the national capital. However, there has been decrease in the number of coronavirus cases in the last few days in Delhi and the city's capacity of conducting RT-PCR tests has significantly has increased. On Saturday, the national capital registered 3,419 new coronavirus cases, taking the infection tally to over 5.8 lakh, while the death toll rose to 9,574 with 77 more fatalities. The new cases came out of a record 81,473 tests, including 35,352 RT-PCR tests and the positivity rate slipped to 4.2 per cent from 4.78 per cent the previous day.

Delhi: 11% symptomatic negative tests of RAT found positive via RT-PCR

A roadside tool for law enforcement may one day fight in the war on COVID-19.

US firm repurposing breathlyzer for COVID-19 testing

A Hong Kong pro-democracy union of healthcare workers and several activists, including Joshua Wong, called on Sunday (August 30) for a boycott of the government's universal coronavirus testing plan, in which medical staff from mainland China are set to assist.

Hong Kong activists urge boycott of mass COVID-19 testing

The federal government released new guidelines saying that asymptomatic people, even those who have been in close contact of an infected person, should not necessarily go for testing. Whereas according to World Health Organisation (WHO), contacts of COVID-19 patients should also be tested regardless of symptoms.

COVID-19: CDC downplays importance of testing asymptomatic people whereas WHO recommends testing suspects

The United States has the biggest COVID-19 testing programme in the world, better than big countries like Russia, China, India and Brazil, President Donald Trump said on Monday, asserting that America has "just about the lowest mortality rate" due to the disease in the world.

"We have one of the lowest mortality rates anywhere," Trump said at a White House roundtable. More than 34 lakh Americans have tested positive for COVID-19 so far and over 1,37,000 have died due to the disease, both of which are the largest numbers among all the countries.

The huge number of positive cases, the president said, is due to the massive testing efforts undertaken by his administration, more extensive than any other country.

"We test more than anybody by far. And when you test, you create cases. So we have created cases. I can tell you that some countries, they test when somebody walks into a hospital sick or walks into maybe a doctor's office, but usually a hospital. That is the testing they do, so they do not have cases, whereas we have all these cases. So, it is a double-edged sword," he said.

At the same time, the United States has the lowest mortality rate or just about the lowest mortality rate due to the disease in the world, Trump added. "We are doing a great job. We are doing very well with vaccines and we are doing very, very well with therapeutics. I think we are going to have some very good information coming out soon," he said in response to a question.

"But we have the best and certainly, by far, the biggest testing programme anywhere in the world. If you tested China or Russia or any of the larger countries, if you just tested India, as an example, the way we test, you would see numbers that would be very surprising. Brazil too. You know, Brazil is going through a big problem, but they do not do testing as we do," Trump said.

"So we do the testing and by doing the testing, we have tremendous numbers of cases. As an example, we have done 45 million tests. If we did half that number, you would have half the cases probably -- around that number. If we did another half of that, you would have half the numbers. Everyone would be saying, ''Oh, we are doing so well on cases," he added.

Responding to a question, Trump said what China did to the world should not be forgotten.

"I think what China has done to the world with what took place -- the China plague -- you can call it the China virus, you can call it whatever you want to call it. It has about 20 different names. What they did to the world should not be forgotten," he said.

The trade deal with China that was signed early this year remains intact, the president said. "It is intact, they (China) are buying. Whether they buy or not, that is up to them. They are buying," he said.

The United States has the biggest COVID-19 testing programme in the world, better than big countries like Russia, China, India and Brazil, President Donald Trump said on Monday, asserting that America has "just about the lowest mortality rate" due to the disease in the world.

The United States has the biggest COVID-19 testing programme in the world, better than big countries like Russia, China, India and Brazil, President Donald Trump said on Monday, asserting that America has "just about the lowest mortality rate" due to the disease in the world. "We have one of the lowest mortality rates anywhere," Trump said at a White House roundtable. More than 34 lakh Americans have tested positive for COVID-19 so far and over 1,37,000 have died due to the disease, both of which are the largest numbers among all the countries. The huge number of positive cases, the president said, is due to the massive testing efforts undertaken by his administration, more extensive than any other country. "We test more than anybody by far. And when you test, you create cases. So we have created cases. I can tell you that some countries, they test when somebody walks into a hospital sick or walks into maybe a doctor's office, but usually a hospital. That is the testing they do, so they do not have cases, whereas we have all these cases. So, it is a double-edged sword," he said. At the same time, the United States has the lowest mortality rate or just about the lowest mortality rate due to the disease in the world, Trump added. "We are doing a great job. We are doing very well with vaccines and we are doing very, very well with therapeutics. I think we are going to have some very good information coming out soon," he said in response to a question. "But we have the best and certainly, by far, the biggest testing programme anywhere in the world. If you tested China or Russia or any of the larger countries, if you just tested India, as an example, the way we test, you would see numbers that would be very surprising. Brazil too. You know, Brazil is going through a big problem, but they do not do testing as we do," Trump said. "So we do the testing and by doing the testing, we have tremendous numbers of cases. As an example, we have done 45 million tests. If we did half that number, you would have half the cases probably -- around that number. If we did another half of that, you would have half the numbers. Everyone would be saying, ''Oh, we are doing so well on cases," he added. Responding to a question, Trump said what China did to the world should not be forgotten. "I think what China has done to the world with what took place -- the China plague -- you can call it the China virus, you can call it whatever you want to call it. It has about 20 different names. What they did to the world should not be forgotten," he said. The trade deal with China that was signed early this year remains intact, the president said. "It is intact, they (China) are buying. Whether they buy or not, that is up to them. They are buying," he said.

US has 'biggest covid-19 testing programme' anywhere in the world, says Trump

'The Bold and the Beautiful', one of the first television series to start filming again, after the COVID induced lockdown and now just a &nbsp;day after resuming, the show has been once again halted.&nbsp;

According to the news agency, the reason behind pausing the production is to accommodate a large volume of coronavirus testing.&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/entertainment/star-wars-actor-mark-hamill-to-headline-virtual-fundraiser-for-joe-biden-306761" hreflang="en">'Star Wars' actor Mark Hamill to headline virtual fundraiser for Joe Biden</a>

"We have paused very briefly to modify our testing protocol to better accommodate the large volume of testing needed. Safety remains our top priority as we continue to move forward with the production of the Bold and the Beautiful. B&amp;B filmed with cast and crew today and it was a successful first day back at work," the news agency quoted a statement.&nbsp;

As the show guidelines involve regular testing for novel coronavirus, ''actors will be tested at least once a week, maybe multiple times a week," the head writer of the show said.&nbsp;

Also read:&nbsp;<a href="https://www.wionews.com/entertainment/jamaican-artist-sues-jay-z-and-beyonce-for-not-giving-her-credit-in-2018-track-black-effect-306726" hreflang="en">Jamaican artist sues Jay-Z and Beyonce for not giving her credit in 2018 track 'Black Effect'</a>

Members will keep six feet away from one another and wear masks on set, and the actors are also required to wear masks when not filming scenes. Actors will also remain at least eight feet apart during filming

After this halt, the shooting of the daytime drama will be resumed from June 23.&nbsp;

'The Bold and the Beautiful', one of the first television series to start filming again, after the COVID induced lockdown and now just a day after resuming, the show has been once again halted.

'The Bold and the Beautiful', one of the first television series to start filming again, after the COVID induced lockdown and now just a day after resuming, the show has been once again halted. According to the news agency, the reason behind pausing the production is to accommodate a large volume of coronavirus testing. Also read: 'Star Wars' actor Mark Hamill to headline virtual fundraiser for Joe Biden "We have paused very briefly to modify our testing protocol to better accommodate the large volume of testing needed. Safety remains our top priority as we continue to move forward with the production of the Bold and the Beautiful. B&B filmed with cast and crew today and it was a successful first day back at work," the news agency quoted a statement. As the show guidelines involve regular testing for novel coronavirus, ''actors will be tested at least once a week, maybe multiple times a week," the head writer of the show said. Also read: Jamaican artist sues Jay-Z and Beyonce for not giving her credit in 2018 track 'Black Effect' Members will keep six feet away from one another and wear masks on set, and the actors are also required to wear masks when not filming scenes. Actors will also remain at least eight feet apart during filming After this halt, the shooting of the daytime drama will be resumed from June 23.

'Bold and the Beautiful' pauses filming to expand COVID-19 testing

National Institute of Virology, Pune has successfully developed the 1st indigenous anti-SARS-CoV-2 human IgG ELISA test kit for antibody detection of #COVID19 . This robust test will play a critical role in surveillance of proportion of population exposed to #SARSCoV2 infection

India's first indigenous COVID-19 testing kit

NYC set to start ‘Self-Swab’ Coronavirus testing. Self-Swab testing could be a better, faster and safer way of doing covid-19 testing. However it needs to be done under the supervision of an expert at the testing center.

NYC set to start ‘Self-Swab’ Coronavirus testing

covid-19-testing

Covid 19 Testing, News on Covid 19 Testing, stories on Covid 19 Testing, articles on Covid 19 Testing, Covid 19 Testing stories at Wion, Covid 19 Testing news, Covid 19 Testing latest news

covid 19-testing